A novel angiographic classification for the endovascular recanalization of symptomatic nonacute extracranial vertebral artery occlusion

医学 闭塞 放射科 椎动脉 血管内治疗 死亡率 外科 冲程(发动机) 心脏病学 动脉瘤 机械工程 工程类
作者
Feng Gao,Hongbo Zheng,Xu Guo,Xuan Sun,Zhongrong Miao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:14 (3): 210-214 被引量:7
标识
DOI:10.1136/neurintsurg-2021-017283
摘要

There remains major uncertainty regarding the optimal therapy for symptomatic nonacute extracranial vertebral artery occlusion (EVAO). Endovascular recanalization for EVAO is technically challenging, and limited data are available. This research aimed to report a multicenter clinical experience of endovascular recanalization for symptomatic nonacute EVAO and establish a novel angiographic classification.From June 2011 to December 2019, 50 symptomatic nonacute EVAO patients treated with endovascular recanalization in three regional referral stroke centers were retrospectively analyzed. All patients were categorized into four groups based on the angiographic classification. The rates of technical success, periprocedural complications, any stroke or death within 1 month, and follow-up data were assessed.The rates of technical success, periprocedural complications, and any stroke or death within 1 month were 86.0% (43/50), 12.0% (6/50), and 4.0% (2/50), respectively. The recanalization rates gradually decreased from Type A to Type D (100%, 94.7%, 80%, and 63.6%, respectively; P=0.007). The EVAO patients in the Type A group with tapered stump and short-segment occlusions showed excellent recanalization effects, with 100% technical success rates and no complications. Conversely, the lowest recanalization rate of 63.6% (7/11) and the highest periprocedural complication rate of 27.3% (3/11) were observed for the Type D group.Endovascular recanalization for symptomatic nonacute EVAO is technically feasible, especially Type A EVAO patients, which can provide an alternative treatment option for recurrent vertebrobasilar ischemia despite optimal medical therapy. The angiographic categorization established in this study is conducive to the selection of suitable patients prior to treatment decision.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慕青应助凡凡采纳,获得10
1秒前
cghmfgh完成签到,获得积分10
2秒前
学无止境应助废寝忘食采纳,获得30
4秒前
4秒前
5秒前
傢誠完成签到,获得积分10
6秒前
震人完成签到,获得积分10
6秒前
7秒前
宋静宇发布了新的文献求助10
8秒前
8秒前
sunny完成签到,获得积分10
8秒前
小灰灰发布了新的文献求助20
8秒前
physicalproblem应助Pony采纳,获得10
9秒前
五岁爱吃蔬菜完成签到 ,获得积分10
9秒前
clausius发布了新的文献求助10
9秒前
hhhh应助云云云采纳,获得10
9秒前
隐形曼青应助十三采纳,获得10
10秒前
科研通AI2S应助ektyz采纳,获得10
10秒前
陈住气发布了新的文献求助10
10秒前
Archers发布了新的文献求助30
13秒前
13秒前
薄饼哥丶发布了新的文献求助10
14秒前
15秒前
cici完成签到,获得积分10
16秒前
研友_Z60ObL完成签到,获得积分10
19秒前
dazuang发布了新的文献求助10
20秒前
20秒前
失眠迎蕾发布了新的文献求助10
20秒前
冯万里完成签到,获得积分10
21秒前
宁宁要去看文献了完成签到,获得积分10
22秒前
马剑完成签到,获得积分10
22秒前
菜菜子完成签到 ,获得积分10
22秒前
23秒前
24秒前
sabrina发布了新的文献求助30
24秒前
clausius完成签到,获得积分10
24秒前
马剑发布了新的文献求助10
25秒前
25秒前
柔弱不能自理完成签到 ,获得积分10
26秒前
可爱的函函应助Pony采纳,获得10
26秒前
高分求助中
【本贴是提醒信息,请勿应助】请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 800
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
comprehensive molecular insect science 500
Challenges, Strategies, and Resiliency in Disaster and Risk Management 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2481446
求助须知:如何正确求助?哪些是违规求助? 2144170
关于积分的说明 5468632
捐赠科研通 1866661
什么是DOI,文献DOI怎么找? 927704
版权声明 563039
科研通“疑难数据库(出版商)”最低求助积分说明 496382